EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Malaria vaccine candidates. The merozoite surface protein-1 (a short review)


Boletin de la Direccion de Malariologia y Saneamiento Ambiental 34(1/4): 22-26
Malaria vaccine candidates. The merozoite surface protein-1 (a short review)
Evidence that the carboxyl-terminus domain of the merozoite surface protein-1 is a candidate for malaria vaccine testing is briefly reviewed.


Accession: 002889382



Related references

Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Vaccine 27(20): 2653-2661, 2009

New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. Vaccine 26(48): 6132-6142, 2008

The major merozoite surface protein as a malaria vaccine target. Parasitology Today 9(8): 300-302, 1993

Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Infection and Immunity 75(3): 1349-1358, 2006

Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infection and Immunity 72(1): 247-252, 2003

Development of a malaria vaccine containing two forms of Plasmodium falciparum merozoite surface protein 2.. 2008

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine. Molecular and Biochemical Parasitology 128(2): 195-204, 2003

Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum. Gene 304(1/2): 65-75, 2003

Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum. Gene 304: 65-75, 2003

Hypervariability in a leading Plasmodium vivax malaria vaccine candidate, C-terminal Merozoite Surface Protein 1. American Journal of Tropical Medicine & Hygiene 62(3 Supplement): 389, March, 2000